Cellectis S.A. current report, Q1 FY2023

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on February 2, 2023. The filing covers the month of February 2023 and serves to distribute a press release dated February 2, 2023, as Exhibit 99.1.

Key Financial Metrics

The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a press release rather than a financial statement.

Material Changes

No material financial changes versus prior periods are detailed in the provided text. The filing references a press release for specific updates, but the content of that release is not included in the source text.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. These details are presumed to be within the referenced press release (Exhibit 99.1), which is not provided in the input.

Investor Verification Checklist

  • Review the full text of the Press Release dated February 2, 2023 (Exhibit 99.1) for specific operational or financial updates.
  • Verify the nature of the announcement made on February 2, 2023, as the Form 6-K itself contains no substantive details.
  • Check subsequent filings for any financial data related to the announcement referenced in this report.